Table 2 Univariable Cox proportional hazard models for NSTEACS patients

From: Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project

	HR (95% CI)	P value
MACE	0.35 (0.16–0.78)	0.010
All-cause death	0.37 (0.14–0.94)	0.036
Myocardial infarction	0.29 (0.07–1.27)	0.100
Stent thrombosis	NA	NA
Ischemic stroke	NA	NA
Major bleeding	0.41 (0.09–1.85)	0.248
Obvious bleeding	0.62 (0.13–2.93)	0.548
Transfusion bleeding	0.50 (0.06–4.26)	0.524
Intracranial bleeding	0.00 (0.00–∞)	0.995
Retroperitoneal bleeding	NA	NA

HR hazard ratios, CI confidence intervals

Back to article page